Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 26 of 38
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Pfizer, Novartis partner to advance treatment of NASH

The companies will conduct both non-clinical and Phase 1 clinical studies of Pfizer’s investigational therapies, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, currently in Phase 2), a Diacylglycerol

EQT offers to buy Karo Pharma for $654m

Karo Pharma develops and markets products for pharmacies and also directly to the healthcare sector. The specialty pharma company is said to have a strong presence in the